A New Jersey-based pharmaceutical company issued a recall of its infants' liquid ibuprofen after discovering higher concentrations of medication the in some packages.
Tris Pharma, Inc. said Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, may potentially have higher concentrations of ibuprofen, which could cause renal failure in susceptible infants. It could be potentially unsafe for babies and could cause nausea, vomiting, epigastric pain or diarrhea.
Below is information on each of the recalled product's labels.
At Walmart, the recalled lots are 00717009A (expiry 02/19), 00717015A (expiry 04/19) and 00717024A (expiry 08/19).
To date, Tris Pharma has not received any reports of adverse events related to the recall. And in Family Dollar, the recalled lot is 00717024A (expiry 08/19).
The drug maker said the recalled lots were sold to a customer who distributes them to retailers, but it's unknown which states are affected.
Consumers with questions regarding this recall can contact Tris Customer Service at 732-940-0358 (Monday through Friday, 8:00 a.m. ET- 5:00 p.m. PT) or via email at mailto:firstname.lastname@example.org.